+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Sclerotherapy Market By Agent (Detergents, Osmotic Agents and Chemical Irritants), By Type (Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy), By Country, Industry Analysis and Forecast, 2020 - 2026

  • ID: 5185474
  • Report
  • October 2020
  • Region: Europe
  • 57 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • LGM Pharma, LLC
  • MTW-Endoskopie W. Haag KG
  • Tianyu Chang’an Group
  • MORE
The Europe Sclerotherapy Market is expected to witness market growth of 7.5% CAGR during the forecast period (2020-2026).

Sclerotherapy is a medical procedure that is used to treat blood vessel or vascular deformities and also any malformations of the lymphatic system. In this procedure, medicine is introduced into the vessels, which results in their shrinking. It is used to treat vascular or lymphatic malformations in children and young adults. In adults, sclerotherapy is also used to treat spider veins, haemorrhoids, and smaller varicose veins.

This condition is beneficial and can be used to treatment by a dermatologist where an irritating medication is introduced into the vein to causes inflammation, fibrosis, endothelial damage, occlusion, and eventually overall absorption of the smaller vessels. In developed countries, about 30.0% of women and 10.0% of men consult the doctor for venous insufficiency signs and symptoms. Various factors like excess weight, heredity, and some professions that require prolonged period of sitting that may increase the risk of chronic venous disease of the legs. Long term thrombosis and varicose veins results in skin pigmentation, skin lesions, dermatitis, eczema, chronic edema, and ulcer.

The attention of both doctors and patients has been shifted towards less-invasive treatment procedures, availability of advanced treatment devices for varicose vein, as well as huge burden of varicose vein cases are the main driving factors in the growth of the market. Other factors include improvement in patient reliability and compliance, increasing healthcare expenditure, and swift growth in aging population.

Based on Agent, the market is segmented into Detergents, Osmotic Agents and Chemical Irritants. Based on Type, the market is segmented into Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Perrigo Company PLC (Omega Pharmaceuticals), Cook Medical, Inc. (Cook Group), Chemische Fabrik Kreussler & Co. GmbH, LGM Pharma, LLC, Troikaa Pharmaceuticals Limited, Tianyu Chang’an Group, Endo-Flex GmbH (Meditek Systems), Merz Pharma GmbH & Co. KGaA, and MTW-Endoskopie W. Haag KG.

Scope of the Study

Market Segmentation:

By Agent
  • Detergents
  • Osmotic Agents
  • Chemical Irritants
By Type
  • Liquid Sclerotherapy
  • Ultrasound Sclerotherapy
  • Foam Sclerotherapy
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Boston Scientific Corporation
  • Perrigo Company PLC (Omega Pharmaceuticals)
  • Cook Medical, Inc. (Cook Group)
  • Chemische Fabrik Kreussler & Co. GmbH
  • LGM Pharma, LLC
  • Troikaa Pharmaceuticals Limited
  • Tianyu Chang’an Group
  • Endo-Flex GmbH (Meditek Systems)
  • Merz Pharma GmbH & Co. KGaA
  • MTW-Endoskopie W. Haag KG
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • LGM Pharma, LLC
  • MTW-Endoskopie W. Haag KG
  • Tianyu Chang’an Group
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Sclerotherapy Market, by Agent
1.4.2 Europe Sclerotherapy Market, by Type
1.4.3 Europe Sclerotherapy Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Europe Sclerotherapy Market by Agent
3.1 Europe Detergents Market by Country
3.2 Europe Osmotic Agents Market by Country
3.3 Europe Chemical Irritants Market by Country

Chapter 4. Europe Sclerotherapy Market by Type
4.1 Europe Liquid Sclerotherapy Market by Country
4.2 Europe Ultrasound Sclerotherapy Market by Country
4.3 Europe Other Type Market by Country

Chapter 5. Europe Sclerotherapy Market by Country
5.1 Germany Sclerotherapy Market
5.1.1 Germany Sclerotherapy Market by Agent
5.1.2 Germany Sclerotherapy Market by Type
5.2 UK Sclerotherapy Market
5.2.1 UK Sclerotherapy Market by Agent
5.2.2 UK Sclerotherapy Market by Type
5.3 France Sclerotherapy Market
5.3.1 France Sclerotherapy Market by Agent
5.3.2 France Sclerotherapy Market by Type
5.4 Russia Sclerotherapy Market
5.4.1 Russia Sclerotherapy Market by Agent
5.4.2 Russia Sclerotherapy Market by Type
5.5 Spain Sclerotherapy Market
5.5.1 Spain Sclerotherapy Market by Agent
5.5.2 Spain Sclerotherapy Market by Type
5.6 Italy Sclerotherapy Market
5.6.1 Italy Sclerotherapy Market by Agent
5.6.2 Italy Sclerotherapy Market by Type
5.7 Rest of Europe Sclerotherapy Market
5.7.1 Rest of Europe Sclerotherapy Market by Agent
5.7.2 Rest of Europe Sclerotherapy Market by Type

Chapter 6. Company Profiles
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Perrigo Company PLC (Omega Pharmaceuticals)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cook Medical, Inc. (Cook Group)
6.3.1 Company Overview
6.4 Chemische Fabrik Kreussler & Co. GmbH
6.4.1 Company Overview
6.5 LGM Pharma, LLC
6.5.1 Company Overview
6.6 Troikaa Pharmaceuticals Limited
6.6.1 Company Overview
6.7 Tianyu Chang’an Group
6.7.1 Company Overview
6.8 Endo-Flex GmbH (Meditek Systems)
6.8.1 Company Overview
6.9 Merz Pharma GmbH & Co. KGaA
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.10. MTW-Endoskopie W. Haag KG
6.10.1 Company Overview
Note: Product cover images may vary from those shown
  • Boston Scientific Corporation
  • Perrigo Company PLC (Omega Pharmaceuticals)
  • Cook Medical, Inc. (Cook Group)
  • Chemische Fabrik Kreussler & Co. GmbH
  • LGM Pharma, LLC
  • Troikaa Pharmaceuticals Limited
  • Tianyu Chang’an Group
  • Endo-Flex GmbH (Meditek Systems)
  • Merz Pharma GmbH & Co. KGaA
  • MTW-Endoskopie W. Haag KG
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll